| scholarly article | Q13442814 |
| P50 | author | Irma Airoldi | Q56468665 |
| Fabio Morandi | Q37830563 | ||
| P2093 | author name string | Vito Pistoia | |
| P2860 | cites work | IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells | Q28214882 |
| Structure and function of the human MHC class Ib molecules HLA‐E, HLA‐F and HLA‐G | Q28279282 | ||
| Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production | Q28350682 | ||
| Development of Th1-type immune responses requires the type I cytokine receptor TCCR | Q28591931 | ||
| Immunotolerant functions of HLA-G. | Q33608225 | ||
| Targeting cytokines in inflammatory diseases: focus on interleukin-1-mediated autoinflammation | Q34167205 | ||
| A role for IL-27p28 as an antagonist of gp130-mediated signaling | Q34688139 | ||
| IFN-gamma protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism | Q34825943 | ||
| IL-27 Imparts Immunoregulatory Function to Human NK Cell Subsets | Q35409867 | ||
| The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses | Q35582560 | ||
| A Specific Interferon (IFN)-stimulated Response Element of the Distal HLA-G Promoter Binds IFN-regulatory Factor 1 and Mediates Enhancement of This Nonclassical Class I Gene by IFN-β | Q57251046 | ||
| Soluble human leukocyte antigen--G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy | Q62513537 | ||
| HLA-E upregulation on IFN-γ-activated AML blasts impairs CD94/NKG2A-dependent NK cytolysis after haplo-mismatched hematopoietic SCT | Q62595296 | ||
| Synergistic effect of IFN-gamma and human cytomegalovirus protein UL40 in the HLA-E-dependent protection from NK cell-mediated cytotoxicity | Q74602327 | ||
| IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes | Q77756347 | ||
| Expression and release of soluble HLA-E is an immunoregulatory feature of endothelial cell activation | Q79441811 | ||
| HLA-G and HLA-E in patients with juvenile idiopathic arthritis | Q83033960 | ||
| Interleukin-27 and interleukin-23 modulate human plasmacell functions | Q83433403 | ||
| Soluble HLA-G: Are they clinically relevant? | Q36384011 | ||
| Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis | Q36400442 | ||
| Interleukin 27: a double-edged sword for offense and defense | Q37607910 | ||
| Interferon-gamma induction of the human leukocyte antigen-E gene is mediated through binding of a complex containing STAT1alpha to a distinct interferon-gamma-responsive element | Q38353983 | ||
| IL-27 in human secondary lymphoid organs attracts myeloid dendritic cells and impairs HLA class I-restricted antigen presentation | Q39247645 | ||
| IL-27 Enhances LPS-Induced Proinflammatory Cytokine Production via Upregulation of TLR4 Expression and Signaling in Human Monocytes | Q39430580 | ||
| Human TCRγδ+ T cells represent a novel target for IL-27 activity. | Q39606012 | ||
| Interleukin-27 induces a STAT1/3- and NF-kappaB-dependent proinflammatory cytokine profile in human monocytes. | Q39697211 | ||
| The secreted form of p28 subunit of interleukin (IL)-27 inhibits biological functions of IL-27 and suppresses anti-allogeneic immune responses | Q39796152 | ||
| Expression and release of HLA-E by melanoma cells and melanocytes: potential impact on the response of cytotoxic effector cells | Q40241649 | ||
| Analysis of HLA-E expression in human tumors | Q40666371 | ||
| HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells | Q40868181 | ||
| Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. | Q40900792 | ||
| HLA-E and HLA-G expression on porcine endothelial cells inhibit xenoreactive human NK cells through CD94/NKG2-dependent and -independent pathways | Q40916618 | ||
| Antigen-presenting function(s) of the non-classical HLA-E, -F and -G class I molecules: the beginning of a story | Q40937118 | ||
| Expression of HLA-G in human mononuclear phagocytes and selective induction by IFN-gamma. | Q41195751 | ||
| An interleukin-6 receptor-dependent molecular switch mediates signal transduction of the IL-27 cytokine subunit p28 (IL-30) via a gp130 protein receptor homodimer | Q41820932 | ||
| Human leukocyte antigen-G expression on dendritic cells induced by transforming growth factor-beta1 and CD4+ T cells proliferation. | Q43181715 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 938561 | |
| P577 | publication date | 2014-03-10 | |
| P1433 | published in | Journal of Immunology Research | Q26841936 |
| P1476 | title | IL-27 driven upregulation of surface HLA-E expression on monocytes inhibits IFN-γ release by autologous NK cells | |
| P478 | volume | 2014 |
| Q90113512 | Decoding the Role of Interleukin-30 in the Crosstalk Between Cancer and Myeloid Cells |
| Q55365932 | Interleukin (IL)-6 Inhibits IL-27- and IL-30-Mediated Inflammatory Responses in Human Monocytes. |
| Q30315505 | Non-classical HLA-class I expression in serous ovarian carcinoma: Correlation with the HLA-genotype, tumor infiltrating immune cells and prognosis |
| Q38840532 | Regulation and trafficking of the HLA-E molecules during monocyte-macrophage differentiation |
Search more.